Fredric L. Coe to Kidney Calculi
This is a "connection" page, showing publications Fredric L. Coe has written about Kidney Calculi.
Connection Strength
18.021
-
Racial Differences in Risk Factors for Kidney Stone Formation. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1166-1173.
Score: 0.585
-
Evidence for disordered acid-base handling in calcium stone-forming patients. Am J Physiol Renal Physiol. 2020 02 01; 318(2):F363-F374.
Score: 0.563
-
Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016 09; 12(9):519-33.
Score: 0.446
-
Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken). 2015 May; 298(5):865-77.
Score: 0.404
-
Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48.
Score: 0.376
-
Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2083-92.
Score: 0.316
-
Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol. 2011 Feb; 300(2):F311-8.
Score: 0.302
-
Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res. 2010 Dec; 38(6):439-52.
Score: 0.300
-
Medicine. Stopping the stones. Science. 2010 Oct 15; 330(6002):325-6.
Score: 0.299
-
Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63.
Score: 0.296
-
Stones. A matter of doubt--how best to evaluate stone formers. Nat Rev Urol. 2010 Sep; 7(9):483-5.
Score: 0.296
-
Evidence for altered renal tubule function in idiopathic calcium stone formers. Urol Res. 2010 Aug; 38(4):263-9.
Score: 0.294
-
Plaque and deposits in nine human stone diseases. Urol Res. 2010 Aug; 38(4):239-47.
Score: 0.294
-
Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 2010 Aug; 78(3):310-7.
Score: 0.289
-
Three pathways for human kidney stone formation. Urol Res. 2010 Jun; 38(3):147-60.
Score: 0.289
-
Evidence for durable kidney stone prevention over several decades. BJU Int. 2009 May; 103(9):1238-46.
Score: 0.262
-
Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007 Feb; 177(2):565-9.
Score: 0.231
-
Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Am J Physiol Renal Physiol. 2006 Nov; 291(5):F1061-9.
Score: 0.227
-
Renal function in patients with nephrolithiasis. J Urol. 2006 Aug; 176(2):600-3; discussion 603.
Score: 0.223
-
Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers. Am J Physiol Renal Physiol. 2006 Sep; 291(3):F530-6.
Score: 0.219
-
Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 2006 Mar; 21(3):701-6.
Score: 0.213
-
Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608.
Score: 0.211
-
Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005 Feb; 67(2):685-90.
Score: 0.201
-
Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003 Dec; 64(6):2150-4.
Score: 0.186
-
Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003 Dec; 64(6):2204-13.
Score: 0.186
-
Endoscopic renal papillary biopsies: a tissue retrieval technique for histological studies in patients with nephrolithiasis. J Urol. 2003 Dec; 170(6 Pt 1):2186-9.
Score: 0.186
-
Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls. Am J Physiol Renal Physiol. 2023 12 01; 325(6):F811-F816.
Score: 0.184
-
A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nat Commun. 2023 07 19; 14(1):4140.
Score: 0.181
-
Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers. Clin J Am Soc Nephrol. 2023 08 01; 18(8):1059-1067.
Score: 0.179
-
Editorial: Something new about stones. J Urol. 2003 Feb; 169(2):478-9.
Score: 0.175
-
Clinical Effectiveness of Calcium Oxalate Stone Treatments. Am J Nephrol. 2022; 53(10):761-766.
Score: 0.173
-
What treatments reduce kidney stone risk in patients with bowel disease? Urolithiasis. 2022 Oct; 50(5):557-565.
Score: 0.170
-
Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients. J Urol. 2002 Jun; 167(6):2372-6.
Score: 0.167
-
Urinary stone risk factors in the siblings of patients with calcium renal stones. J Urol. 2002 May; 167(5):1965-7.
Score: 0.166
-
Stone Morphology Distinguishes Two Pathways of Idiopathic Calcium Oxalate Stone Pathogenesis. J Endourol. 2022 05; 36(5):694-702.
Score: 0.166
-
A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002 Apr; 167(4):1607-12.
Score: 0.165
-
Does a failure of crystal inhibition cause calcium renal stones? Nephron. 2002 Apr; 90(4):361-4.
Score: 0.165
-
Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int. 2002 Mar; 61(3):975-87.
Score: 0.164
-
Patient adherence to long-term medical treatment of kidney stones. J Urol. 2001 Dec; 166(6):2057-60.
Score: 0.162
-
Agreement of Food Records and 24-Hour Urine Studies in Clinical Practice. J Ren Nutr. 2022 01; 32(1):51-57.
Score: 0.159
-
Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers. Physiol Rep. 2021 07; 9(13):e14943.
Score: 0.157
-
Relative contributions of urine sulfate, titratable urine anion, and GI anion to net acid load and effects of age. Physiol Rep. 2021 05; 9(10):e14870.
Score: 0.155
-
Discrepancy Between Stone and Tissue Mineral Type in Patients with Idiopathic Uric Acid Stones. J Endourol. 2020 03; 34(3):385-393.
Score: 0.142
-
In Vivo Renal Tubule pH in Stone-Forming Human Kidneys. J Endourol. 2020 02; 34(2):203-208.
Score: 0.142
-
Prevention of recurrent nephrolithiasis. Am Fam Physician. 1999 Nov 15; 60(8):2269-76.
Score: 0.140
-
Reduced crystallization inhibition by urine from men with nephrolithiasis. Kidney Int. 1999 Oct; 56(4):1505-16.
Score: 0.139
-
Mechanisms for falling urine pH with age in stone formers. Am J Physiol Renal Physiol. 2019 07 01; 317(7):F65-F72.
Score: 0.135
-
Divergence between stone composition and urine supersaturation: clinical and laboratory implications. J Urol. 1999 Apr; 161(4):1077-81.
Score: 0.134
-
Association Between Randall's Plaque Stone Anchors and Renal Papillary Pits. J Endourol. 2019 04; 33(4):337-342.
Score: 0.134
-
Beverages, diet, and prevention of kidney stones. Am J Kidney Dis. 1999 Feb; 33(2):398-400; discussion 401-3.
Score: 0.133
-
Medical reduction of stone risk in a network of treatment centers compared to a research clinic. J Urol. 1998 Nov; 160(5):1629-34.
Score: 0.131
-
Randall's plaque in stone formers originates in ascending thin limbs. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1236-F1242.
Score: 0.128
-
Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1998 Jun; 159(6):1821-5.
Score: 0.127
-
Renal stone disease in older adults. Clin Geriatr Med. 1998 May; 14(2):367-81.
Score: 0.126
-
Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770.
Score: 0.126
-
Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. J Urol. 1998 Mar; 159(3):664-8.
Score: 0.125
-
Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int. 1997 Dec; 52(6):1602-8.
Score: 0.122
-
Papillary Ductal Plugging is a Mechanism for Early Stone Retention in Brushite Stone Disease. J Urol. 2018 01; 199(1):186-192.
Score: 0.120
-
Diet and calcium: the end of an era? Ann Intern Med. 1997 Apr 01; 126(7):553-5.
Score: 0.117
-
New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res. 1997 Apr; 12(4):522-33.
Score: 0.117
-
Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997 Mar; 51(3):894-900.
Score: 0.116
-
Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla. J Endourol. 2017 01; 31(1):85-90.
Score: 0.115
-
The financial effects of kidney stone prevention. Kidney Int. 1996 Nov; 50(5):1706-12.
Score: 0.114
-
Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. J Am Soc Nephrol. 1996 Apr; 7(4):602-7.
Score: 0.109
-
Stone formation in genetic hypercalciuric rats. Kidney Int. 1995 Dec; 48(6):1705-13.
Score: 0.107
-
A Proposed Grading System to Standardize the Description of Renal Papillary Appearance at the Time of Endoscopy in Patients with Nephrolithiasis. J Endourol. 2016 Jan; 30(1):122-7.
Score: 0.106
-
Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease. J Urol. 2015 Nov; 194(5):1308-12.
Score: 0.103
-
Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 01; 309(1):R85-92.
Score: 0.102
-
Mechanisms of human kidney stone formation. Urolithiasis. 2015 Jan; 43 Suppl 1:19-32.
Score: 0.097
-
Micro-CT imaging of Randall's plaques. Urolithiasis. 2015 Jan; 43 Suppl 1:13-7.
Score: 0.097
-
An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int. 1994 Jun; 45(6):1722-30.
Score: 0.096
-
Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis. Acta Urol Belg. 1994 Jun; 62(2):25-9.
Score: 0.096
-
Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis. Miner Electrolyte Metab. 1994; 20(6):378-84.
Score: 0.093
-
A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol Renal Physiol. 2013 Dec 01; 305(11):F1574-84.
Score: 0.092
-
Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013 Mar; 14(4):435-47.
Score: 0.088
-
The pathogenesis and treatment of kidney stones. N Engl J Med. 1992 Oct 15; 327(16):1141-52.
Score: 0.086
-
Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int. 2012 Jun; 81(11):1140-8.
Score: 0.082
-
Stone-forming potential of milk or calcium-fortified orange juice in idiopathic hypercalciuric adults. Kidney Int. 1992 Jan; 41(1):139-42.
Score: 0.081
-
Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals. Am J Physiol. 1991 Nov; 261(5 Pt 2):F824-30.
Score: 0.080
-
Inhibitors within the nephron. Am J Kidney Dis. 1991 Apr; 17(4):407-13.
Score: 0.077
-
Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol. 1991 Apr; 260(4 Pt 2):F569-78.
Score: 0.077
-
Hereditary aspects of calcium nephrolithiasis. Adv Nephrol Necker Hosp. 1991; 20:31-40.
Score: 0.076
-
Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8.
Score: 0.069
-
In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 2010 Jan; 105(2):242-5.
Score: 0.068
-
Trends in kidney donation among kidney stone formers: a survey of US transplant centers. Am J Nephrol. 2009; 30(1):12-8.
Score: 0.066
-
Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol. 1988 Dec; 255(6 Pt 2):F1197-205.
Score: 0.066
-
A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 2009 Apr; 103(7):966-71.
Score: 0.065
-
Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8.
Score: 0.065
-
Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94.
Score: 0.064
-
Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6.
Score: 0.064
-
Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 1988 Jun; 33(6):1140-6.
Score: 0.063
-
Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008 Jul; 74(2):223-9.
Score: 0.063
-
Pathophysiology of kidney stones and strategies for treatment. Hosp Pract (Off Ed). 1988 Mar 15; 23(3):185-9, 193-5, 199-200 passim.
Score: 0.062
-
Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken). 2008 Mar; 291(3):325-34.
Score: 0.062
-
Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol. 2008 Mar; 28(2):111-9.
Score: 0.062
-
New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. 2008 Mar; 28(2):120-32.
Score: 0.062
-
Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis. Kidney Int. 1987 Nov; 32(5):749-53.
Score: 0.061
-
Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken). 2007 Oct; 290(10):1315-23.
Score: 0.061
-
Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid. J Clin Invest. 1987 Jun; 79(6):1782-7.
Score: 0.059
-
The pathogenesis of calyceal diverticular calculi. Urol Res. 2007 Feb; 35(1):35-40.
Score: 0.058
-
Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007 Apr; 71(8):795-801.
Score: 0.058
-
The role of Randall's plaques in the pathogenesis of calcium stones. J Urol. 2007 Jan; 177(1):31-8.
Score: 0.057
-
A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int. 1986 Jul; 30(1):85-90.
Score: 0.055
-
Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 2006 Jun; 69(12):2227-35.
Score: 0.055
-
Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 2006 May; 175(5):1720-4; discussion 1724.
Score: 0.055
-
Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 2006 Apr; 69(8):1313-8.
Score: 0.055
-
Recurrent renal calculi. Causes and prevention. Hosp Pract (Off Ed). 1986 Mar 30; 21(3A):49-57.
Score: 0.055
-
Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol. 1986; 208:445-9.
Score: 0.054
-
A new animal model of hyperoxaluria and nephrolithiasis in rats with small bowel resection. Urol Res. 2005 Nov; 33(5):380-2.
Score: 0.053
-
Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis. J Clin Invest. 1985 Oct; 76(4):1455-62.
Score: 0.053
-
Insights on the pathology of kidney stone formation. Urol Res. 2005 Nov; 33(5):383-9.
Score: 0.052
-
Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005 Aug; 46(2):263-9.
Score: 0.052
-
Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 2005 Jul; 68(1):145-54.
Score: 0.052
-
Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res. 2005 May; 33(2):105-15.
Score: 0.051
-
Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91.
Score: 0.050
-
Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol. 2005 Jan; 173(1):117-9; discussion 119.
Score: 0.050
-
Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab. 1985; 11(4):267-9.
Score: 0.050
-
Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85.
Score: 0.049
-
Pathophysiology of hypercalciuria. Am J Physiol. 1984 Jul; 247(1 Pt 2):F1-13.
Score: 0.048
-
Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983 Sep; 24(3):392-403.
Score: 0.046
-
Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest. 2003 Mar; 111(5):607-16.
Score: 0.044
-
Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003 Feb; 63(2):662-9.
Score: 0.044
-
Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int. 1982 Oct; 22(4):366-70.
Score: 0.043
-
Prevention of kidney stones. Am J Med. 1981 Oct; 71(4):514-6.
Score: 0.040
-
Hyperuricosuria and calcium nephrolithiasis. Urol Clin North Am. 1981 Jun; 8(2):227-44.
Score: 0.039
-
Nephrolithiasis: causes, classification, and management. Hosp Pract (Hosp Ed). 1981 Apr; 16(4):33-45.
Score: 0.039
-
Clinical use of cystine supersaturation measurements. J Urol. 2000 Nov; 164(5):1481-5.
Score: 0.037
-
Idiopathic hypercalciuria in calcium nephrolithiasis. Dis Mon. 1980 Sep; 26(12):1-36.
Score: 0.037
-
Acclerated calcium nephrolithiasis. JAMA. 1980 Aug 22-29; 244(8):809-10.
Score: 0.037
-
Stone disease in hereditary distal renal tubular acidosis. Ann Intern Med. 1980 Jul; 93(1):60-1.
Score: 0.037
-
Uric acid saturation in calcium nephrolithiasis. Kidney Int. 1980 May; 17(5):662-8.
Score: 0.036
-
Recurrence of renal stones. Lancet. 1980 Mar 22; 1(8169):651.
Score: 0.036
-
Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease. Scand J Urol Nephrol Suppl. 1980; 53:171-7.
Score: 0.035
-
The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl. 1980; 53:265-71.
Score: 0.035
-
Treatment of renal calculi. Adv Intern Med. 1980; 26:373-92.
Score: 0.035
-
Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980; 128:439-50.
Score: 0.035
-
Calcium-uric acid nephrolithiasis. Arch Intern Med. 1978 Jul; 138(7):1090-3.
Score: 0.032
-
Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int. 1978 May; 13(5):418-26.
Score: 0.032
-
Nephrolithiasis during pregnancy. N Engl J Med. 1978 Feb 09; 298(6):324-6.
Score: 0.031
-
Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med. 1977 Oct; 87(4):404-10.
Score: 0.030
-
The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis. 1976 Dec; 29(12):793-800.
Score: 0.029
-
Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19; 291(25):1344-50.
Score: 0.025
-
The performance of a computer system for metabolic assessment of patients with nephrolithiasis. Comput Biomed Res. 1974 Feb; 7(1):40-55.
Score: 0.023
-
Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet. 1973 Jan 20; 1(7795):129-31.
Score: 0.022
-
Nephrocalcinosis: re-defined in the era of endourology. Urol Res. 2010 Dec; 38(6):421-7.
Score: 0.019
-
Defenses of an unstable compromise: crystallization inhibitors and the kidney's role in mineral regulation. Kidney Int. 1990 Oct; 38(4):625-31.
Score: 0.019
-
A diagnostic approach to the patient with renal stones. Med Times. 1970 Oct; 98(10):87-94.
Score: 0.019
-
Nephrolithiasis and gestation. Baillieres Clin Obstet Gynaecol. 1987 Dec; 1(4):909-19.
Score: 0.015
-
Nephrolithiasis in pregnancy. Am J Kidney Dis. 1987 Apr; 9(4):354-8.
Score: 0.015
-
Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis. Trans Assoc Am Physicians. 1985; 98:281-9.
Score: 0.013
-
Secondary hyperparathyroidism in children with symptomatic idiopathic hypercalciuria. J Pediatr. 1983 Dec; 103(6):932-5.
Score: 0.012
-
Calcium nephrolithiasis and medullary sponge kidney in women. N Engl J Med. 1982 May 06; 306(18):1088-91.
Score: 0.010
-
Formation of a single calcium stone of renal origin. Clinical and laboratory characteristics of patients. Arch Intern Med. 1982 Mar; 142(3):504-7.
Score: 0.010
-
Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan; 72(1):17-24.
Score: 0.010
-
Hyperparathyroidism in nephrolithiasis. Arch Intern Med. 1980 Nov; 140(11):1479-81.
Score: 0.009
-
Does mild, asymptomatic hyperparathyroidism require surgery? N Engl J Med. 1980 Jan 24; 302(4):224-5.
Score: 0.009
-
Familial idiopathic hypercalciuria. N Engl J Med. 1979 Feb 15; 300(7):337-40.
Score: 0.008
-
Urinary saturation measurements in calcium nephrolithiasis. Ann Intern Med. 1979 Feb; 90(2):180-4.
Score: 0.008
-
Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 1998 Jan; 53(1):194-9.
Score: 0.008
-
Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr. 1978 Jun; 92(6):906-10.
Score: 0.002